Home / Transcripts / NewLake Capital Partners, Inc. (NLCP) · May 8, 2026

NewLake Capital Partners, Inc. (NLCP) Earnings Call Transcript & Summary

May 8, 2026

OTC Pink Market US Real Estate Industrial REITs earnings 35 min

What were the key takeaways from NewLake Capital Partners, Inc.'s May 8, 2026 earnings call?

In the first quarter of 2026, NewLake Capital Partners reported total revenue of $12.3 million, a decrease from $13.2 million in the prior year, while adjusted funds from operations (AFFO) were $10.1 million or $0.48 per share. The company maintained its dividend at $0.43 per share, supported by a 90% AFFO payout ratio. Management highlighted the significant regulatory milestone of medical cannabis rescheduling to Schedule III, which is expected to improve operator cash flow and credit profiles, potentially enhancing NewLake's portfolio performance and future growth opportunities.

What topics did NewLake Capital Partners, Inc. cover?

What were NewLake Capital Partners, Inc.'s May 8, 2026 results?

NewLake Capital Partners is navigating a challenging environment with a strong balance sheet and a disciplined approach to risk management. The recent regulatory changes present potential catalysts for growth, but ongoing sector challenges, including operator bankruptcies, remain a risk. Investors should monitor leasing activity and regulatory developments closely as they could significantly impact future performance.

Earnings Call Speaker Segments

Valter Pinto executive
#1

Thanks, operator, and good morning to all of you. It's a pleasure to welcome everyone to New Lake Capital Partners' conference call covering the financial results for the first quarter of 2026. With me today are Gordon DuGan, our Chairman; Anthony Coniglio, who serves as President and Chief Executive Officer; and Lisa Meyer, our Chief Financial Officer. Before getting started, I want to remind you that some remarks we make on this call could be deemed forward-looking in accordance with the safe harbor provisions contained in the Private Securities Litigation Reform Act of 1995, and actual outcomes might differ materially because of numerous risks and uncertainties. On this call, we will also discuss non-GAAP financial measures, such as FFO and AFFO. You can find reconciliations to the most directly comparable GAAP measures in our earnings release. Having said that, I would now like to hand the call over to our Chairman, Gordon DuGan.

Gordon DuGan executive
#2

Thanks, Valter, and good morning to all of you. For the cannabis sector, 2026 looks set to be a pivotal year. Medical cannabis was rescheduled not long ago, marking a significant regulatory step forward, and after a long stretch of ambiguity, we're finally seeing real movement. The shift of cannabis to Schedule III represents a landmark development and starts to tackle a major structural obstacle facing the industry — specifically, the weight of 280E taxes. Down the road, this shift could boost operators' cash flow and credit standing, and it might also pave the way for additional reforms, such as better entry to capital markets and the chance of retroactive 280E relief. On top of that, other pending moves, like a possible ban on synthetic THC, could reinforce the industry's long-term fundamentals. That said, even though these steps are positive, conditions stay tough for some operators — for instance, the cannabis company recently said it had begun bankruptcy proceedings in Canada. Anthony will get into our particular exposure and how we're positioned in greater depth, but what happened there makes clear the financial and operational strain that still exists in portions of this sector. It also shows why we've always taken a careful, disciplined approach to this market instead of presuming that regulatory wins by themselves would swiftly lead to better fundamentals. Given that setting, our team keeps concentrating on proactively handling portfolio risk, working to reposition assets when it makes sense, enhance lease terms, and safeguard long-term value; we stay disciplined as we steer through today's conditions while readying the business to gain from the longer regulatory and industry tailwinds once they arrive — ideally before long. Crucially, the strength of our balance sheet — we're the sole REIT I'm aware of carrying no debt — along with how reliably we generate cash flow and the steadiness of our dividend, continue to be key points of distinction for New Lake. In the first quarter, we produced $0.48 of AFFO and announced a first quarter 2026 dividend of $0.43 per share, which was paid on April 15. Since our IPO in 2021, we've now distributed cumulative dividends totaling $7.29 per share. We have been, and remain, the company best positioned to handle this industry's challenges and capture its opportunities. With that, I'll hand the call over to Anthony.

Anthony Coniglio executive
#3

Thanks, Gordon, and hello everyone on this call. This is a thrilling moment for the cannabis space, and there's plenty to discuss today. I'll start with what we delivered in the first quarter. Then I'll move on to what's been happening on the regulatory front recently, share some portfolio news, and wrap up with an update on our leasing efforts. Our Q1 performance came in right where we thought it would. Every dollar of contractual rent came through during the quarter, and our AFFO payout ratio stood at 90%, which gives us plenty of room to cover the $0.43 dividend for the first quarter. We feel good about these numbers given the ongoing pressures across the cannabis sector. The industry has dealt with serious challenges during the last several years, and in our view the portfolio has shown its durability amid a tough operating backdrop, thanks to careful underwriting and an emphasis on 4-wall coverage. Now shifting to the wider policy picture; there's notable movement happening on both the federal side and among the states. Federally speaking, moving medical cannabis to Schedule III amounts to the biggest reform this industry has seen in more than 50 years. The Department of Justice formally acknowledging accepted medical use, along with the departure from Schedule I, represents a pivotal regulatory moment that points toward ongoing normalization and greater legitimization for the industry. Rescheduling removes the use of 280E for operators who are compliant, and that should boost tenant cash flow, lift credit profiles, and help the whole sector gain better access to capital. We see this as a favorable credit event for every one of our tenants. We're also paying close attention to what the Treasury Department and IRS say about how these changes get implemented. If any relief ends up applying retroactively for 280E, that could substantially strengthen operator balance sheets by cutting down uncertain tax position liabilities that have built up over the years. Clearing those liabilities would bolster overall financial health and, crucially, bring tenant credit risk down even further throughout our portfolio. By our estimate, roughly 50% to 55% of our annualized base rent right now comes from medical cannabis activities, which are now regarded as federally legal activities. That matters when it comes to exchange listing eligibility, since the legal status of what our tenants do remains a gating factor for getting listed on the New York and NASDAQ. Importantly, we already satisfy the other applicable listing requirements, and we see the rescheduling of medical cannabis as a significant step toward continued normalization of our business and our capacity over time to gain access to a major U.S. exchange. On top of that, we expect the broader rescheduling effort and — pardon me, the broader rescheduling effort covering nonmedical cannabis activities to wrap up later this year, which, if it succeeds, could put NewLake in a strong position to satisfy all the exchange listing requirements. Adding further support to the industry's long-term prospects is the federal government's plan to ban intoxicating hemp-derived THC products, with that ban slated to go into effect in November 2026. We think that removing these items — which go head-to-head with the tenants we oversee under state rules — will act as one more favorable force driving higher revenue throughout our tenant roster, though the degree will differ based on the regions where those tenants do business. On the state front, we keep witnessing positive movement; in Virginia, a recreational-use bill might yet be enacted notwithstanding the <<inaudible>> disagreements separating the legislature and the governor, and we are tracking that result carefully. In Massachusetts, changes to the cannabis framework, such as elevated ownership limits and broader operational latitude, ought to boost how competitive the market is and reinforce the business climate for those holding licenses. We are likewise picking up fresh signals from Indiana and North Carolina about possible medical cannabis initiatives after the medical marijuana rescheduling news. On the whole, we anticipate that reform at the state level will keep advancing, which ought to bolster the industry's long-term underpinnings. Even so, shifts in regulation do not instantly fix the balance sheet and operational difficulties already in place. Although the developments just mentioned are positive, the present business climate is still tough for particular operators, and that fact keeps showing up throughout the sector. A case in point is the cannabis company, which lately filed for bankruptcy in Canada under that nation's CCAA rules. Although this filing was not wholly a surprise, given wider sector trends and the creditor forbearance we brought up last quarter, it does highlight the persistent financial pressure bearing down on some operators. As for what we are exposed to, New Lake right now leases 4 properties to the cannabis company: a dispensary plus a cultivation site in Illinois, and a dispensary plus cultivation site in Massachusetts. The cannabis company is still up to date on rent, and we retain roughly 1 month of security deposits tied to these properties. Alongside the bankruptcy filing, the cannabis company revealed it had reached several deals to offload assets or businesses in multiple states, among them Illinois and Massachusetts, where our properties sit. We are busily assessing how this process might affect the properties we lease to them, and we are proactively cultivating interest in these assets in case the cannabis company eventually defaults and we move to regain possession. We will keep watching how things develop and give investors updates when warranted. On a wider note, reducing risk stays a key priority throughout the portfolio. In the quarter, we brought a stronger operator into our San Diego dispensary through a new lease, put Holistic Industries in as an extra guarantor at one of our Pennsylvania cultivation sites, and brought Canopy USA into the guarantor arrangement at our Massachusetts cultivation facility leased to Acreage. Taken together, these moves substantially boost the credit quality of these assets; when it comes to our leasing pipeline, we are busy promoting our vacant properties and have noticed a rise in activity. Reform in Massachusetts has generated greater interest, and since the federal rescheduling news in April, talks with possible tenants across the properties have increased more widely. As we have said before, we do not publicize letters of intent and will only share updates after lease agreements are executed. Retenanting doesn't happen overnight, but the inbound interest we're seeing and the caliber of operators looking at our assets give us encouragement. To wrap up: with historic reform unfolding and federal cannabis laws changing, New Lake is set up well to gain — our balance sheet is conservative, our dividend is well supported, and our portfolio strategy stays disciplined, centered on safeguarding capital right now while putting the company in position to seize better industry fundamentals and future investment chances as time goes on. On that note, I'll hand things to Lisa so she can take everyone through the financials in detail.

Lisa Meyer executive
#4

Thanks, Anthony, and good morning, everyone. Turning to the first quarter of 2026, we brought in total revenue of $12.3 million, down from $13.2 million during the same period a year earlier. Net income attributable to common stockholders came to $5.8 million, which works out to $0.28 per share. Funds from operations were $9.7 million, or $0.46 per share. Adjusted funds from operations reached $10.1 million, equal to $0.48 per share. The decline in revenue and AFFO on a year-over-year basis stemmed mainly from 3 cultivation facilities that are available for lease across Pennsylvania, Nevada and Massachusetts — these lowered rental income and raised property carrying costs. That drag was partly offset by a full quarter of rental income from 2 dispensaries acquired in 2025, plus annual contractual rent escalators that averaged 2.6% throughout the portfolio. Total expenses came down slightly versus the prior year period, largely because of reduced reimbursable property expenses and lower general and administrative expenses, though property carrying costs partly offset that. On March 4, 2026, our Board of Directors declared a first quarter cash dividend of $0.43 per share, or $1.72 per share on an annualized basis. That dividend was paid on April 15, 2026, to stockholders of record as of May 31, 2026, and it reflects an AFFO payout ratio of approximately 90%, which stays inside our target range of 80% to 90% and fully supports the sustainability of our dividend. As of March 31, 2026, we held $24.8 million of cash along with total liquidity of approximately $107.2 million, including availability under our revolving credit facility. Just $7.6 million was outstanding under that facility, leaving $82.4 million of remaining capacity. We continue to keep a highly conservative balance sheet, with debt at 1.6% of total gross assets, a debt service coverage ratio of approximately 72x and no debt maturities until May of 2027. All in all, our results for the quarter matched expectations. We stay focused on preserving a strong balance sheet while managing risk throughout our portfolio; given our liquidity and conservative leverage profile, we believe we're well positioned to pursue growth opportunities as the regulatory environment for cannabis continues to evolve. Operator, please open the line for questions.

Craig Kucera analyst
#5

I valued the details regarding leasing interest in Massachusetts, though I'm also curious whether you're noticing growing interest at the Nevada and Pennsylvania properties you hold that sit empty?

Anthony Coniglio executive
#6

Correct. I'd describe it as happening broadly — we've witnessed more interest in properties. One caveat I'd offer: an increase in interest alone doesn't guarantee it will close in the end. Still, without question, the conversations have picked up.

Gordon DuGan executive
#7

And Anthony, probably fair to say maybe more in the other 2 than Massachusetts.

Craig Kucera analyst
#8

That's additional interest, right? Would you say that's accurate? Do you share that view?

Anthony Coniglio executive
#9

Absolutely. I do.

Craig Kucera analyst
#10

All right. That's a great point. Switching topics here, does the rescheduling shift your view of the acquisition landscape, especially when it comes to the medical-use segment?

Anthony Coniglio executive
#11

No. Not at all. We keep evaluating 4-wall coverage and whether rent gets covered by the cash flow generated at a given site, and if medical operations turn more profitable thanks to 280E going away, sure, that helps over the long haul. Yet the truth is that across the past 2 years, medical operators weren't directing cash flow toward paying the 280E piece of their taxes; instead they let that obligation build up, as I noted during the prepared remarks, within their uncertain tax position line item on the balance sheet. So we won't contemplate adjusting until we truly observe a lasting shift in a property's cash flow profile stemming from these changes. Still, I believe our underwriting process has worked well for us so far, and we intend to stay with that same approach.

Craig Kucera analyst
#12

All right, understood. Considering what you just announced — and like you said during your remarks, this is the industry's largest development in 50 years — have you picked up on more talk about M&A among operators?

Anthony Coniglio executive
#13

Absolutely. We've been hearing a lot of discussion around that. There are sizable — especially among the publicly traded companies, some of the bigger operators face substantial public company costs. So in a merger scenario, those platforms have what you might call easy wins within reach. State regulations make this tricky, though, along with possible overlap and the regulatory timeline required to divest assets in a combination. In fact, during the past 4 years, certain larger deals fell apart and got called off since they couldn't satisfy those divestiture obligations. Still, we're definitely picking up more talk on this, and our view is that within the coming 18 to 24 months, a few of these should make it over the finish line.

Craig Kucera analyst
#14

All right. I'd like to return to what you said about getting listed on an exchange. With that 50% to 55% medical figure, does that let you qualify in a meaningful way? Or does some other gatekeeping element stand in the way? Is 100% what's required? Or what's the right way for us to frame that?

Anthony Coniglio executive
#15

Yes. Let's begin by revisiting, once more, the reason we aren't on a major exchange. From a governance standpoint and from the standpoint of listing requirements, we meet every criterion, except that all of our tenants sit in the cannabis sector. Those illegal activities are the actual gating item. What we hoped to point out is that since roughly 50% of our revenues now come from a federally legal activity — one we're working to phase out; really it's the regulatory environment, not us, that's shifting toward a place where, ideally, at some future point, all of our revenue activity originates from fully legal channels. How long that might take can't be predicted. When the exchanges determine enough is enough can't be predicted. Whether guidance comes from treasury can't be predicted, but since the rescheduling we've gotten some questions about what level of activity is legal now, and that's the reason we gave that information.

Gordon DuGan executive
#16

I could simply tack something onto that, though it comes down to a judgment call. There isn't any — no federal statute governs what the exchanges are permitted to do here. So plainly, that's a judgment call. As you're — as you're certainly aware, at least 1 REIT is already listed on the New York Stock Exchange doing precisely the same thing we do. And still, that company has kept its listing. And I've never truly received a completely coherent explanation for why that one is listed while we aren't; so it's a judgment call, and we keep talking with the major exchanges to figure out when we reach that tipping point. And when that will be, we simply don't know.

Craig Kucera analyst
#17

All right. So, I'm wondering — among the operators you work with, are any who currently lack a medical license now going after one, given how potentially advantageous that could be on taxes? And maybe you're even nudging them in that direction?

Anthony Coniglio executive
#18

To be clear, we aren't pushing anyone. It's not our place to instruct tenants on operating their businesses. Looking across our portfolio, nearly every property we hold has a license shared with medical. That's a key reason we can reach that split of 50% to 50% in revenue, since even where medical is shared, a given dispensary might predominantly do adult-use sales too. I believe just 2 dispensaries are adult-use only. What we keep observing and being told anecdotally happens at the register — and this applies industry-wide, not merely within our portfolio — is that consumers get encouraged to use their medical marijuana card when they hold one. So in my view, operators themselves are seeking ways to shift more of their sales into the medical category. Beyond that, I've been picking up talk about regulators in different states exploring how to widen medical access for consumers and grow the portion of their program sitting in the federally legal category, because consider how many states that legalized — especially with social equity licensees — handed out many of those licenses in more of an adult-use framework, since those entrants joined the program at a later stage. That leaves state regulators worried that currently, certain social equity licensees can't enjoy the upside of a move to Schedule III. As a result, they're attempting to determine how to stay properly within federal rules while expanding the reach of medical sales within their own jurisdictions. To sum all of it up: everyone is highly conscious of the financial upside from doing away with 280E, and they're searching for ways to guarantee that upside extends further — reaching additional licensees and additional transactions.

Pablo Zuanic analyst
#19

Regarding the agreements involving Canopy Growth, or possibly Canopy U.S.A. — to clarify, a guarantee was placed on the Massachusetts lease, correct? But what about the Pennsylvania one? I'm trying to grasp the mechanics of why one state got it and the other didn't, and whether this was done through CUSA or through CGC. Then, if I may tack on a related follow-up, Anthony, staying on this same subject: when it comes to cannabis, as far as I know, we're aware of who purchased their Ohio assets. You've been discussing Illinois, and Massachusetts came up. Do we know who the buyers are for the cannabis assets in those 2 states?

Anthony Coniglio executive
#20

Pablo, let's rewind on your first question. Roughly 2 years back, we held 3 acreage properties. A dispensary of ours tied to acreage went to a company named Butter, and through that deal, we managed to obtain a guarantee from Green Thumb Industries, GTI; that left us with 2 properties. In our Q, we disclosed that a financing transaction was entered into at the Pennsylvania property associated with acreage. Through that arrangement, a guarantee came to us from holistic industries; additionally, through the same arrangement, we were able to lock in a guarantee on the Massachusetts property from Canopy USA. You might be aware that Canopy USA serves as the top U.S. holding company not only for Acreage but for Wana, Jetty, and the minority stake in TerrAscend as well, and in the past, an acreage guarantee was all we had. So, before I turn to cannabis, did that cover your question?

Pablo Zuanic analyst
#21

Yes. Thank you.

Anthony Coniglio executive
#22

Regarding cannabis, the identity of the possible purchaser for the Illinois properties and the Massachusetts properties hasn't been made public at this point. What cannabis has said is that for assets in 6 or 7 states that are left following the Ohio and Delaware sale—which the bankruptcy court approved a couple of weeks back—there are multiple buyers. I want to repeat that the cannabis properties keep paying rent and are up to date as of today. May rent has been paid, and April rent too. So we will keep watching what takes place with the properties. And whether some or all of our properties are included in those deals, and what kind of buyers those are. Meanwhile, we aren't simply relying on hope as our approach. We're working hard to generate interest in these assets in case cannabis proves unable to close transactions for them.

Pablo Zuanic analyst
#23

Moving to a different topic — regarding the tenants you have that aren't publicly traded, obviously the bulk of your portfolio involves publicly listed MSOs, whose financial statements we can review. Still, any details you're able to share in this open setting would, from my perspective, be useful, particularly regarding bigger tenants like C3 codes and Mint. Clearly, I can conduct my own analysis on those, but any insight you could offer here would help.

Anthony Coniglio executive
#24

Sure. Naturally, my hands are somewhat tied because these are privately held entities. Regarding Mint and C3, here's what I can share: previously, they've issued public comments indicating they operate businesses producing free cash flow and operate profitable businesses. As I see those operations, they've kept running them in a manner consistent with earlier years. Another point about C3 — based on their public commentary — is that for the past 18 months, their primary emphasis has been expanding their dispensary footprint. Consequently, I anticipate that 2026 will be a year marked by substantially better and greater revenue along with cash flow, as those dispensaries and retail locations come into operation. Turning to another privately held company of ours, Calypso — a cultivation operation based in Pennsylvania — it's a fully federally compliant business currently, thanks to medical cannabis rescheduling, since it operates in just one state. That definitely strengthens their standing, as all of their transactions involve medical sales. So we possess solid visibility, Pablo, not only into the companies' broader financial results, but my real emphasis is on the individual property level. You heard me mention during the prepared remarks that our underwriting centers on 4-wall coverage. I consider that equally crucial — perhaps even more so — compared to the corporate financial picture as a whole, since the strongest protection against financial trouble is a property capable of producing free cash flow for its tenant. Such properties tend to endure and maintain strong demand, even when you must shift to a different tenant. Also, we reveal — within our investor presentation — the EBITDAR coverage ratios for our assets; and in my view, what you'd observe is that these have remained fairly consistent throughout the portfolio.

Pablo Zuanic analyst
#25

Thanks, that helps a lot. Let's go back to the possibility that NewLake could move up to a major exchange. Obviously, if the hearings lead to rescheduling of REG, then the entire business becomes fully legal, in theory, right — we'll just have to wait and watch how that plays out. But suppose REG stays only partly legal while medical remains legal — could you then split into 2 companies, with NewLake acting, say, as a leasing business that provides financing to — that holds lease contracts with medical operators, and let that entity be leased? Is that something that could occur, or would it make sense from an efficiency standpoint?

Anthony Coniglio executive
#26

Yes. Pablo, I would prefer not to guess about the steps we might take. Here's what I can say about our possible actions — actually, here's what we're committed to doing: the moment we have clarity on the regulations, the Board will convene, review what lies ahead, and determine the path that serves our shareholders best. Should pursuing a deal like that be the right call, we might go that route; on the other hand, if holding the business as one unit makes more sense, we might choose that instead. So I'd rather not speculate on hypotheticals. We'll wait and see how this plays out. My guess is the timeline won't stretch out much, since those hearings kick off in late June, wrap up sometime in July, and after that the administrative law judge needs a while to hand the report over to the DEA administrator prior to any final rule coming down. So in my view, we aren't looking at years before we know how this lands — more like months, possibly a couple of quarters, and once we have that answer, we'll decide what route serves shareholders best.

Pablo Zuanic analyst
#27

From where I sit, though, that wouldn't open up many opportunities for your business. A lot of those properties may already be under lease. The chance is more likely to come — and it might be for mortgage REITs or BDCs that lend against cash flow, if there's M&A, correct? Yet if one company wants to buy another, I doubt that generates opportunities on your end, though please tell me if I've got that wrong. At the same time, what are you picking up about expansion plans in Virginia and Texas? In Texas, it appears to me that folks are somewhat in a wait-and-see posture when it comes to greater clarity on the regulations. And in Virginia, naturally, let's see what unfolds between the governor and the legislature, right? Still, any detail there would be useful.

Anthony Coniglio executive
#28

Yes, Pablo. Thanks for asking. Let's begin by recalling for everyone where AFFO growth comes from for us. There are 4 primary buckets. First is our built-in escalators. As Lisa said before, 2.6% annual rent escalators throughout the portfolio; so AFFO increases from that. Second would be funding any TI. Right now, we're at a low point with TI remaining, with roughly $375,000 of TI left to disburse; once that money is funded, we begin collecting rent on it. Third would be leasing our available properties, which would clearly deliver additional AFFO; and fourth would be new transactions. So when it comes to your question about consolidation, there are in fact billions of dollars of real estate sitting on MSO balance sheets. It will still be there even following a combination. The reason it stays there is that the cost of capital relative to the need for capital and the cost of capital objectives for the operators hasn't yet converged. And so as our cost of capital declines over time, with the normalization, hopefully moving to a better exchange, witnessing the normalization of cannabis and the improved valuation of the assets and cash flows we hold. Keep in mind, we have almost 12 years of duration on our portfolio. What I believe you'll see is our offerings converging with the yield targets the operators are seeking, and it will stop being economic for them to keep those assets in any significant way on their balance sheet. So I still foresee a future for transactions, for people to shed burdens from their balance sheets; regarding growth, you brought up Texas. Texas has been an extremely, extremely nascent market, and that whole market has to be built out. So there will be substantial investment needs in Texas. Georgia is another state we're keeping an eye on. We believe Georgia could be an outstanding state, and that's been one more quite early-stage initiative that has seen considerable growth when it comes to conditions and what we believe that market might turn into; therefore investment will be required there. A bit of limited investment in Virginia and, without a doubt, build-out will be needed, though not on a large scale. Then additional states may enter; and we've heard Indiana and North Carolina now discussing the possibility of medical marijuana programs; and once those programs launch, capital will be required to construct real estate much as you're witnessing in Kentucky with its expanding medical program. So I believe there's still ample growth ahead in the future. It comes down to how long those states take to activate; and the final thing I want to address regarding your question concerned operators not being especially active. What I believe operators are doing is demonstrating a highly cautious stance on capital allocation, especially in Texas; we aren't seeing any scramble to build. I believe operators want reforms that last. They want to handle their balance sheets properly before they assume expansion CapEx. They want to ensure they possess robust stability in their existing operations; and I believe that is a cautious stance.

Anthony Coniglio executive
#29

We appreciate all of you being with us on this call, and our thanks go out to each member of the NewLake team. Enjoy the rest of your day.

Operator operator
#30

Also, everyone, we appreciate you joining us. That wraps up the call for today. Please feel free to hang up your phones now, and we hope the rest of your day is great.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete NewLake Capital Partners, Inc. transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

For developers and AI pipelines

Programmatic access to NewLake Capital Partners, Inc. earnings transcripts and 132,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.